Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Inopak Ltd
WARNING LETTER
•Inopak Ltd•July 20, 2018

Inopak Ltd – FDA Warning Letter, Jul 20, 2018

Record Details

The FDA issued a Warning Letter to Inopak Ltd. on February 21, 2019, following an inspection from July 11 to 20, 2018, at their Ringwood, New Jersey drug manufacturing facility. The inspection revealed significant violations of current good manufacturing practice (CGMP) regulations (21 CFR, parts 210 and 211), rendering their drug products adulterated under section 501(a)(2)(B) of the FD&C Act.

Key violations include: 1. **Failure to investigate discrepancies (21 CFR 211.192):** Inopak Ltd. failed to thoroughly investigate out-of-specification (OOS) microbial limit test results for Inofoam batch #7302, which led to a recall. Their response was inadequate as it lacked proposed corrective and preventive actions (CAPA) and failed to extend the investigation to other batches. The FDA requires enhanced quality unit oversight, identification of adverse laboratory control trends, resolution of laboratory variation causes, and investigations into potential manufacturing causes. 2. **Lack of stability data (211.137(a)):** The firm could not provide stability data to support the three-year expiration dates for Inofoam, Derma Gel, and Saniguard. Their response, stating they were "exploring options," was deemed inadequate due to the absence of an

Company
Inopak Ltd
Inspection date
July 20, 2018
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 8cfd00c6-76c3-455e-afb3-0692eb7345bc

Violation Codes7
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.137(a)21 CFR 211.22(d)21 CFR 211.100(a)

Full citation text and observation details available on the Dashboard.

Other documents for Inopak Ltd
  • 483 - 2023-08-03August 3, 2023
  • 483 - 2018-07-20July 20, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Inopak Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.